(Q38419338)

2 September 2017

1 reference

title

Treatment of Eczema: Corticosteroids and Beyond (English)

1 reference

2 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869743%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Luz Fonacier

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869743%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

14 April 2015

1 reference

Clinical Reviews in Allergy & Immunology

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869743%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869743%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869743%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

249-262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25869743%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12016-015-8486-7

9 June 2020

exact match

0 references

cites work

Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Management of difficult-to-treat atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Atopic dermatitis: a practice parameter update 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Effect of moisturizers on epidermal barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Frequency of application of topical corticosteroids: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Integration of Notch 1 and calcineurin/NFAT signaling pathways in keratinocyte growth and differentiation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Loss of calcineurin Aalpha alters keratinocyte survival and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid-pretreated skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Treatment of acute exacerbated atopic eczema with emollient-antiseptic preparations using the "wet wrap" ("wet pajama") technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

A pilot study on the use of wet wraps in infants with moderate atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Treatment of refractory atopic dermatitis using 'wet-wrap' dressings and diluted corticosteroids: results of standardized treatment in both children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Efficacy of crisis intervention treatment with topical corticosteroid prednicarbat with and without partial wet-wrap dressing in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

A randomised study of "wet wraps" versus conventional treatment for atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Efficacy and problems associated with using a wet-wrap garment for children with severe atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Relieving the pruritus of atopic dermatitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Role of bacterial superantigens in atopic dermatitis : implications for future therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Recurrent MRSA skin infections in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

The role of antiseptic agents in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Use of bleach baths for the treatment of infected atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Bacterial skin colonization and infections in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Nasal versus bronchial and nasal response to oral aspirin challenge: Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-γ-producing CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Climatic factors are associated with childhood eczema prevalence in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Vitamin D deficiency in reproductive age Mongolian women: a cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Potential barriers to adherence in pediatric dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Patient perspectives on the management of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

The role of contact dermatitis in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Evaluation of food allergy in patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

The atopy patch test in the diagnostic workup of suspected food-related symptoms in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Dietary exclusions for established atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

The diagnostic value of atopy patch testing and prick testing in atopic dermatitis: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Induction of atopic dermatitis by inhalation of house dust mite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

A randomized trial of methotrexate versus azathioprine for severe atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Recombinant interferon gamma therapy for atopic dermatitis

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

21 January 2018

12 December 2020

Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Immunology of atopic dermatitis: novel insights into mechanisms and immunomodulatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Anti-immunoglobulin E in the treatment of refractory atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

The use of biologicals in cutaneous allergies - present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Specific immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Prevalence of eczema and food allergy is associated with latitude in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8486-7

Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis

21 January 2018

1 reference

12 December 2020

Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial

1 reference

12 December 2020

The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study

1 reference

12 December 2020

Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis

1 reference

12 December 2020

Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study

1 reference

12 December 2020

Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study

1 reference

12 December 2020

Anti-CD20 (rituximab) treatment improves atopic eczema

1 reference

12 December 2020

Evaluation of the utility of atopy patch testing, skin prick testing, and total and specific IgE assays in the diagnosis of cow's milk allergy

1 reference

12 December 2020

Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma

1 reference

12 December 2020

Azathioprine: old drug, new actions

1 reference

12 December 2020

Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis

1 reference

12 December 2020

Lipid abnormalities in atopic dermatitis

1 reference

12 December 2020

Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity.

1 reference

12 December 2020

The status of corticosteroid therapy in dermatology

1 reference

12 December 2020

Stealth monitoring of adherence to topical medication: Adherence is very poor in children with atopic dermatitis

1 reference

12 December 2020

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Anti-CD20 (rituximab) treatment for atopic eczema

1 reference

12 December 2020

Topical corticosteroids

1 reference

12 December 2020

Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis

1 reference

12 December 2020

Contact hypersensitivity to hydrocortisone-free-alcohol in patients with allergic patch test reactions to tixocortol pivalate

1 reference

12 December 2020

The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelines

1 reference

12 December 2020

Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study

1 reference

12 December 2020

Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study

1 reference

12 December 2020

Topical glucocorticosteroids

1 reference

12 December 2020

Screening for corticosteroid contact hypersensitivity

1 reference

12 December 2020

Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of corticosteroid dilution

1 reference

12 December 2020

The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis

1 reference

12 December 2020

Contact allergy to glucocorticosteroids in patients with chronic venous leg ulcers, atopic dermatitis and contact allergy

1 reference

12 December 2020

Occlusive therapy in atopic dermatitis: overview

1 reference

12 December 2020

Systemic contact dermatitis.

1 reference

12 December 2020

Atopic dermatitis: the (wet) wrap-up

1 reference

12 December 2020

Viral infections in atopic dermatitis Pathogenic aspects and clinical management

1 reference

12 December 2020

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

1 reference

12 December 2020